Prevalence of type 2 diabetes is increasing worldwide for various reasons ([@CIT0001]). However, indigenous populations have been more adversely affected ([@CIT0002]--[@CIT0005]). In Canada, many First Nations people live in environments that promote development of chronic diseases, such as diabetes and heart disease. Many aspects of this environment are rooted in the legacy of colonialism and include limited incomes ([@CIT0006]), low educational attainment ([@CIT0007]), limited access to affordable foods ([@CIT0008]), reduced access to health care ([@CIT0009]) and racism ([@CIT0002]).

In Manitoba, the prevalence of diabetes is over 4 times higher among First Nations people compared with non-First Nations people ([@CIT0003]). Similar gaps in prevalence of diabetes have been noted more recently among First Nations populations compared with non-First Nations people in Saskatchewan ([@CIT0004]) and Alberta ([@CIT0005]), with higher prevalence noted among First Nations women compared with men ([@CIT0004], [@CIT0005]). Other studies based on the First Nations community have also reported high prevalence of diabetes ([@CIT0010]--[@CIT0012]). In the study community of Sandy Bay First Nation, Manitoba, the diabetes burden is similarly heavy, with an age- and sex-standardized prevalence of 39% among adults ([@CIT0007]). Furthermore, the study community is within the Dakota Ojibway Tribal Council, which has the highest adjusted prevalence of diabetes among adults compared with all other Tribal Councils in Manitoba, at approximately 25% ([@CIT0009]).

While diabetes prevalence has been well described in Canadian First Nations populations ([@CIT0003]--[@CIT0005], [@CIT0007], [@CIT0010]--[@CIT0012]), incidence has not, particularly recent estimates. Incidence is important to understanding the trajectory of the epidemic (i.e. Are people continuing to develop diabetes and, if so, how is incidence distributed within the population?). Among researchers who have reported on incidence, estimates were derived from either administrative data ([@CIT0003], [@CIT0004]) or hospital registries ([@CIT0010]). Chart review, administrative and registry data have many strengths but one disadvantage of each is that they rely on diagnosed cases, and the issue of undiagnosed cases, particularly in marginalized populations, is well established ([@CIT0013], [@CIT0014]). To our knowledge, there has been only one Canadian longitudinal study with First Nations people (Sandy Lake, ON) that included measures of glucose metabolism at baseline and follow-up; however, the sample size was small (n=95), follow-up was 4 years and the sample was not based on population but consisted of high-risk individuals only ([@CIT0015], [@CIT0016]). Population-based studies are required to determine incidence of diabetes, particularly in communities where diabetes burden is high and the age of onset is young. In addition, previous studies from Sandy Lake First Nation that reported diabetes incidence did not report incident hypertension or dyslipidemia ([@CIT0017]--[@CIT0019]), yet these cardiometabolic conditions are important contributors to the development of diabetes, diabetes complications and other chronic disease, particularly in the First Nations population. Therefore, the purpose of the study was to determine incidence rates of diabetes, hypertension and dyslipidemia in a population-based cohort from one Manitoba First Nation community.

Methods {#S0002}
=======

Framework {#S0002-S20001}
---------

This study was approached using a community-based participatory research (CBPR) framework. Briefly, we have applied the core aspects of CBPR described by Israel et al. ([@CIT0020]): (a) the participatory component is to take into account local context; (b) there should be co-operation and equal contribution between community members and researcher(s); (c) co-learning of both the researcher(s) and community; (d) capacity building in the local community and expanding the "strength and resources in community," which included 4 community research assistants; (e) empowerment to reduce social inequities; (f) a balance between research and action or policy change, which may or may not include a direct "action" component, so that all partners can benefit. Initially, the community identified the health issues and sought out university researchers; a Community Diabetes Advisory Group was then established. The Community Diabetes Advisory Group includes members of the community health centre, community members and university researchers. In this regard, the community, by way of a Community Diabetes Advisory Group, was involved in the design, data collection, analysis, interpretation, presentation and publication of the study results. The group met regularly prior to, during, and following data collection to discuss and plan all these components.

Design {#S0002-S20002}
------

The study community is Sandy Bay Ojibway First Nation, located in southwest Manitoba, approximately 200 km northwest of Winnipeg. This community is accessible year round by road. The total on-reserve population in 2011 was approximately 4,100 people with 50% younger than 19 years.

All adults, 18 years and older and non-pregnant, were invited to a Diabetes Screening Study in 2002/2003 (convenience sample) ([@CIT0007]); 36% of the eligible population participated (n=1,346) ([@CIT0007]). Inclusion criteria included being a registered member of Sandy Bay First Nation or a registered member of another First Nation but living in Sandy Bay. Eligible individuals were invited through advertisements on the community radio station and health centre, as well as home visits from community research assistants. Two of the three community research assistants were elders and familiar with the majority of the residents in the community. This sample was representative of the community population in 2002/2003 according to age, sex and employment ([@CIT0007]). In 2011/2012, a second Diabetes Screening Study was completed ([@CIT0013]). Targeted recruitment of participants from the 2002/2003 sample was employed to optimize the longitudinal sample size. Specifically, we identified participants from the 2002/2003 study who were known to be alive and residing in the community; community research assistants then personally invited those participants to return for the 2011/2012 study through home visits. The community research assistants who were also elders were able to identify those that had passed away or moved. The studies were approved by the University of Manitoba Health Research Ethics Board (H2001:178; H2011:171).

Data collection and laboratory procedures {#S0002-S20003}
-----------------------------------------

In both 2002/2003 and 2011/2012, venous blood samples were drawn by a registered nurse after a minimum 12-h fast, processed on site at the health centre and stored at −20°C. Details of the biochemical analysis have been previously described ([@CIT0007], [@CIT0013]). Briefly, fasting glucose levels were determined using the hexokinase/glucose-6-phosphate dehydrogenase assay. Lipids were determined using enzymatic colorimetric methods. Two blood pressure readings were taken after a 5 min rest, both initially and between readings, and averaged. All anthropometric measures were taken by trained research assistants using established methods previously described ([@CIT0007], [@CIT0013]). Participants' medical histories, including previous diagnosis of diabetes or hypertension, as well as medication use, were obtained by questionnaire administered by a research assistant.

Definition of cardiometabolic conditions {#S0002-S20004}
----------------------------------------

Diabetes is defined as currently on an oral hypoglycaemic, self-declared or fasting glucose ≥7.0 mmol/L ([@CIT0021], [@CIT0022]). Impaired fasting glucose (IFG) is defined as a fasting glucose between 6.1 and 6.9 mmol/L ([@CIT0021]). Hypertension is defined as a previous diagnosis of hypertension; or systolic blood pressure (SBP) \>140 mm Hg or diastolic blood pressure (DBP) \>90 mm Hg; or for participants with diabetes, SBP≥130 mm Hg or DBP≥80 mm Hg ([@CIT0021], [@CIT0022]). Dyslipidemia is defined as a fasting plasma triglycerides ≥1.7 mmol/L, in combination with a fasting plasma high-density lipoprotein cholesterol (HDL-C) \<1.03 mmol/L (for men) or plasma HDL-C\<1.3 mmol/L (for women) ([@CIT0013], [@CIT0023]).

Statistical analyses {#S0002-S20005}
--------------------

First, descriptive analysis of the 2002/2003 sample and the longitudinal cohort at baseline were completed according to age group, sex, highest level of education complete, employment status, diabetes, obesity, hypertension and dyslipidemia. Age groups were: 18--29, 30--39, 40--49 and 50 years and older. Highest level of education completed was dichotomized according to median grade level in the 2002/2003 sample. Employment status included any work for pay, including part-time and full-time. Obesity is defined as body mass index ≥30 kg/m^2^. Differences between the baseline sample and the sample with follow-up data were tested using chi-square statistic and independent sample *t*-test. We acknowledge that the 2 samples are not independent; however, mixed models accounting for repeated measurements did not converge.

The number of new cases of each of the relevant conditions was determined together with a 95% CI to demonstrate the reliability of the estimate for the population. Only participants without the respective condition at baseline were included in the denominator. The number of incident cases of diabetes was also identified as either previously diagnosed during the follow-up period or detected at screening (i.e. undiagnosed). Incidence density was also determined, assuming a diagnosis at mid-point of follow-up; this assumes incidence was constant throughout the study period. We acknowledge that incidence density, in this case, has several limitations; it is reported to facilitate comparison to the literature.

Age group, age as a continuous variable, and sex were explored as potential predictors of incident disease (diabetes, hypertension and dyslipidemia) using a generalized linear model with Poisson distribution. The relative risk according to age group and sex is reported, not controlling for the other in each respective analysis. All statistical analyses were conducted using the current version of SPSS (version 22) with significance set at p\<0.05.

Results {#S0003}
=======

Of 478 participants from 2002/2003, 171 returned in 2011/2012 comprising 36% of the original sample. Similarly, 37% of participants without diabetes at baseline returned at follow-up (n=128). Although attempts were made to recruit the 2002/2003 participants for the 2011/2012 study, a larger number than anticipated moved, passed away, refused to participate or could not be located. A description of the study sample at baseline is provided in [Table I](#T0001){ref-type="table"}. In addition, a comparison to the overall sample in 2002/2003 was included to verify the representativeness of the cohort. The prospective cohort was 2 years younger compared with the baseline sample, which was mostly accounted for by fewer participants aged older than 50 years at baseline. However, the 2 samples were not significantly different according to sex, education, employment, marital status, diabetes, obesity or hypertension prevalence at baseline.

###### 

Description of longitudinal study sample at baseline compared with the 2002/2003 sample

  Variables                                                     Longitudinal sample (n=171)   2002/2003 sample (n=478)   p
  ------------------------------------------------------------- ----------------------------- -------------------------- ----------------------------------------
  Age                                                           35.7±9.6                      37.8±12.3                  0.041[a](#TF0001){ref-type="table-fn"}
  Age groups at enrolment                                                                                                0.009
   18--29 years                                                 48 (28.1)                     142 (29.5)                 
   30--39 years                                                 65 (38.0)                     144 (29.9)                 
   40--49 years                                                 44 (25.7)                     108 (22.4)                 
   ≥50 years                                                    14 (8.2)                      88 (18.3)                  
  Sex                                                                                                                    0.834
   Men                                                          80 (46.8)                     230 (47.7)                 
   Women                                                        91 (53.2)                     252 (52.3)                 
  Highest level of education[b](#TF0002){ref-type="table-fn"}                                                            0.465
   \<grade 9                                                    83 (49.7)                     248 (53.0)                 
   ≥grade 9                                                     84 (50.3)                     220 (47.0)                 
  Employed                                                                                                               0.237
   Yes                                                          41 (24.1)                     137 (28.8)                 
   No                                                           129 (75.9)                    338 (71.2)                 
  Diabetes                                                                                                               0.329
   Yes                                                          43 (25.1)                     140 (29.0)                 
   No                                                           128 (74.9)                    342 (71.0)                 
  Hypertension                                                                                                           0.510
   Yes                                                          64 (37.9)                     192 (40.8)                 
   No                                                           105 (62.1)                    279 (59.2)                 
  Obese                                                                                                                  0.940
   Yes                                                          94 (56.3)                     265 (56.6)                 
   No                                                           73 (43.7)                     203 (43.4)                 

Data are presented as either mean (SD) or *n* (%). The p-value refers to the result from a chi-square test unless otherwise noted.

The p-value refers to the result from an independent sample *t*-test.

Highest level of education was dichotomized according to median in 2002/2003.

Diabetes {#S0003-S20001}
--------

There were 35 (95% CI: 26, 45) new cases of diabetes among 128 participants without diabetes at baseline (27 or 3.3% per year); the incidence density is 38.6 cases/1,000 person-years. Thirty-four per cent (12/35) of the incident cases were newly identified at screening, that is, undiagnosed. Among the 13 cases of IFG at baseline, 9 cases had progressed to diabetes (69 or 8.4% per year). Among participants with normal glucose tolerance at baseline (n=115), 10 (95% CI: 5, 16) had progressed to IFG and 26 (95% CI: 18, 35) to diabetes.

Compared with participants aged 18--29 at baseline, participants aged 50 years and older had 4 times the risk of developing diabetes (p=0.012) ([Table II](#T0002){ref-type="table"}). Participants 40--49 years old had more than 2 times the risk of developing diabetes compared with the youngest age group; however, this trend did not reach significance (p=0.078). Another important note regarding the age of incidence cases was that more than 50% of new diagnoses were among participants less than 40 years old at baseline. Risk of incident diabetes was not significantly different between men and women (p=0.771).

###### 

Risk of incident diabetes, hypertension and dyslipidemia according age and sex

  Condition      Characteristic     Incident cases   Number at risk   Relative risk (95% CI)   p
  -------------- ------------------ ---------------- ---------------- ------------------------ -------
  Diabetes       Age at enrolment                                                              
                  18--29 years      9                44               Reference                
                  30--39 years      9                51               0.863 (0.342, 2.173)     0.754
                  40--49 years      12               27               2.173 (0.916, 5.157)     0.078
                  ≥50 years         5                6                4.074 (1.365, 12.156)    0.012
                 Age (continuous)                                     1.051 (1.013, 1.091)     0.008
                 Sex                                                                           
                  Men               15               58               Reference                
                  Women             20               70               1.105 (0.566, 2.158)     0.771
  Hypertension   Age                                                                           
                  18--29 years      13               41               Reference                
                  30--39 years      12               42               0.901 (0.411, 1.975)     0.795
                  40--49 years      8                18               1.402 (0.581, 3.382)     0.452
                  ≥50 years         3                3                3.154 (0.899, 11.067)    0.073
                 Age (continuous)                                     1.033 (0.994, 1.073)     0.101
                 Sex                                                                           
                  Men               24               51               Reference                
                  Women             12               53               0.481 (0.241, 0.962)     0.039
  Dyslipidemia   Age                                                                           
                  18--29 years      13               38               Reference                
                  30--39 years      5                41               0.356 (0.127, 1.000)     0.050
                  40--49 years      7                25               0.818 (0.327, 2.051)     0.669
                  ≥50 years         3                8                1.096 (0.312, 3.847)     0.886
                 Age (continuous)                                     1.000 (0.963, 1.039)     0.985
                 Sex                                                                           
                  Men               12               59               Reference                
                  Women             16               53               1.484 (0.702, 3.137)     0.301

Hypertension {#S0003-S20002}
------------

There were 36 (95% CI: 31, 42) new cases of hypertension among 104 participants without hypertension at baseline (34.6%). Age was not significantly associated with incident hypertension as either a categorical or continuous variable ([Table II](#T0002){ref-type="table"}). Also, women had half the risk of developing hypertension compared with men (p=0.039).

Dyslipidemia {#S0003-S20003}
------------

There were 28 (95% CI: 20, 37) new cases of dyslipidemia at follow-up among 112 participants without dyslipidemia at baseline (25%). Risk of dyslipidemia was not significantly different between the age groups or sex ([Table II](#T0002){ref-type="table"}). Of note, 46% (13/28) of new cases of dyslipidemia were among participants 18--29 years old at baseline.

Discussion {#S0004}
==========

In the present study, the cumulative incidence of diabetes was 27% over 8.2 years and the incidence density was 38.6 cases/1,000 person-years. The higher rate among participants 50 years and older reported here is consistent with the previous report in Manitoba First Nations in which diabetes risk increases with age ([@CIT0003]). Incidence density of diabetes reported among other indigenous populations ([@CIT0003]--[@CIT0005], [@CIT0024]--[@CIT0026]) is summarized in [Table III](#T0003){ref-type="table"}. Incidence rates have varied across different indigenous groups and over time. In Sandy Lake First Nation, an incidence rate of 17.5% over 10 years among individuals ≥10 years old at baseline was reported between 1995 and 2005 ([@CIT0017]). The incidence rate in the study community confirms a high rate in another First Nation group, as well as the persistence of a high incidence in a later time period as well as perhaps an increase in incidence over time. While the incidence rate appears to be highest in the study community, direct comparisons between studies are not possible due to different dates surveyed, age groups included, age structure of the population and/or method of diabetes identification.

###### 

Comparison of diabetes incidence rates in Indigenous populations

  Population                                            Incidence rate per 1,000 person-years           Age at enrolment   Time period                     Method of diabetes identification   References
  ----------------------------------------------------- ----------------------------------------------- ------------------ ------------------------------- ----------------------------------- ---------------
  Sandy Bay First Nation (Manitoba, Canada)             38.6                                            ≥18 years old      2002/2003--2011/2012            Self-report and fasting glucose     Present study
  Australian Aboriginal communities (remote, central)   20.3                                            15--77 years old   1987--1995                      2-h oral glucose tolerance test     ([@CIT0024])
  Manitoba First Nations population                                                                     ≥20 years old      1994--1998                      Administrative data                 ([@CIT0003])
   Men                                                  21.1                                                                                                                                   
   Women                                                21.1 (estimated based on other data provided)                                                                                          
  Albertan First Nations population                                                                     ≥20 years old      1995--2007                      Administrative data                 ([@CIT0025])
   Men                                                  10.3                                                                                                                                   
   Women                                                11.9                                                                                                                                   
  Saskatchewan First Nations population                                                                 ≥20 years old      1980--2005 (incidence density   Administrative data                 ([@CIT0004])
   Men                                                  17.80                                                              for 2003 reported)                                                  
   Women                                                17.95                                                                                                                                  
  Kahnawá:ke First Nation                                                                               ≥18 years old      1986--1988                      Administrative data                 ([@CIT0010])
   Men                                                  8.8                                                                2001--2003                                                          
   Women                                                8.8                                                                                                                                    
   Men                                                  7.0                                                                                                                                    
   Women                                                5.2                                                                                                                                    
  American Pima Indians                                                                                                    1991--2003                      2-h oral glucose                    ([@CIT0026])
   (Gila River Indian                                   9.4                                             15--24 years old                                   tolerance test                      
   Community in Arizona)                                22.6                                            25--34 years old                                                                       
                                                        43.4                                            35--44 years old                                                                       
                                                        49.8                                            45--54 years old                                                                       
                                                        70.8                                            55--64 years old                                                                       
                                                        43.4                                            ≥65 years old                                                                          

Incident diabetes was not significantly different between men and women in the present study. In contrast, Green et al. ([@CIT0003]) reported a higher diabetes incidence among First Nations women compared with First Nations men in Manitoba. However, the authors also reported an increasing incidence of diabetes over time for First Nations men compared with a plateau for First Nations women in Manitoba during the 1990s; this finding supports the reduction in the diabetes gap between First Nations men and women over time and as the epidemic advances. We have also reported no sex difference in diabetes prevalence in the study community in either 2002/2003 or 2011/2012 ([@CIT0013]).

An important finding with regard to diabetes and all conditions is the high burden of risk among young adults. Over 50% of incident cases of diabetes were among participants less than 40 years old at baseline. Like diabetes, we would expect incident dyslipidemia and hypertension to increase with age; however, this was not the case. These findings are consistent with previously published results from the cross-sectional portion of these studies, which highlight the burden of disease among young adults ([@CIT0013], [@CIT0027]--[@CIT0029]). Due to the longitudinal design of this study, this finding supports the persistence of developing disease among young adults in this population. The burden of risk among young adults is also important with respect to diabetes complications; younger age of onset of type 2 diabetes is associated with greater risk of diabetes complications ([@CIT0030]) and a higher risk of mortality and complications compared with type 1 diabetes ([@CIT0031]). In addition, undiagnosed diabetes continues to be a problem in the study community with a third of incident cases being previously undiagnosed. We have previously reported that in the 2002/2003 sample, 24% of those with diabetes were unaware of their condition ([@CIT0027]). Diagnosis of diabetes is critical in managing blood glucose and preventing/delaying complications ([@CIT0014]).

Men had a 50% higher risk of developing hypertension compared with women. There was a sex difference in prevalence of hypertension in 2011/2012 that was not detected in 2002/2003 ([@CIT0013]). This sex difference in prevalence may be partly explained by the difference of incidence of hypertension between men and women reported here. It appears as though changes in blood pressure operate independently of adiposity and lipid metabolism in this population given the differing patterns (both prevalence and incidence) of hypertension and other cardiometabolic conditions ([@CIT0013]). It is also possible that the changes in prevalence of hypertension may reflect changes in lifestyle habits in the population. In this regard, the prevalence of smoking increased among men in the community, but not women ([@CIT0028]). Another potential contributor is sex differences in health service use; men, in general, are less likely to seek primary care. In addition, family physician availability in the community is limited with physician services available one half-day per week (Joanne Roulette, Director of the Health Centre, 2011, oral communication, 16th of April). This is also a young population with a high fertility rate (Joanne Roulette, Director of the Health Centre, 2011, oral communication, 16th of April), which leads to greater screening for hypertension among women. On another note, the higher incidence of hypertension among men may partially explain the higher risk of end-stage renal disease observed among First Nation men compared with women despite higher rates of diabetes among First Nation women compared with men ([@CIT0032]).

The results presented here are important for the Sandy Bay community health centre to govern their services. Given the study community is rural and has year-round access to urban centres, they operate under a health centre model. For this reason, the structure of services in place (i.e. a walk-in clinic type model) is not designed to address the needs of individuals who are chronically ill. Furthermore, with such a high burden of disease, the focus of the health centre is on treatment, which results in being in the difficult position of having to direct limited resources to what is supposed to be their prime mandate: prevention (Joanne Roulette, Director of the Health Centre, 2014, oral communication, 14th of April).

Strengths of this study include the CBPR framework and the richness of the data, including diabetes screening rather than use of administrative data. Limitations include the use of a convenience sample at baseline which may not be representative of the population based on factors other than age, sex or employment; the large loss-to-follow-up and subsequent small sample size. The large loss-to-follow-up may be partially attributed to the challenges of conducting studies in a rural community and may have resulted in underreporting of incident cardiometabolic conditions. Specifically, young adults from the community tend to be very geographically mobile (Joanne Roulette, Director of the Health Centre, 2012, oral communication, 5th of June). Limitations specific to estimating incidence density include the assumption of a mid-point time of diagnosis given that diabetes incidence is not consistent over time ([@CIT0033]) and the limited measurement of exposure time for the majority of the population, given the large loss-to-follow-up. The use of fasting glucose as opposed to an oral glucose tolerance test is also considered a limitation, as incidence may be underestimated ([@CIT0034]). Finally, the results of this study have limited external generalizability. However, it is unlikely that the results presented are unique to this First Nation community given similar risk factors and sociodemographic characteristics in some Manitoba communities and others in Canada.

In conclusion, the incident rate of diabetes, hypertension and dyslipidemia in this population are high compared with other First Nations populations, especially given the young age structure of the population. Although this is the first report of incidence in the community, these results indicate the persistence of disease among young adults previously reported ([@CIT0013], [@CIT0029], [@CIT0030], [@CIT0034]) and suggest that a high burden of diabetes complications in the study community will continue. These results are needed by the study community to prioritize their resources and importantly to advocate for a restructuring of their funding to accommodate the disease burden.
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